NCT00390338View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2012

Study Completion Date

January 31, 2015

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

polarized dendritic cells

BIOLOGICAL

non-polarized dendritic cells

Trial Locations (2)

15213

UPMC Cancer Center at Magee-Womens Hospital, Pittsburgh

15232

UPMC Cancer Centers, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Pawel Kalinski

OTHER

NCT00390338 - Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | Biotech Hunter | Biotech Hunter